Doç. Dr. SİNEM NİHAL ESATOĞLU

Yayın Ağı

Makaleler 96

1. EULAR recommendations for the management of Behçet’s syndrome: 2025 update

HATEMİ G., Ramiro S., ÖZGÜLER Y., ESATOĞLU S. N., Tomasson G., Barete S., et al.

Annals of the Rheumatic Diseases , cilt.85, sa.6, ss.1010-1025, 2026 (SCI-Expanded, Scopus)

2. A critical look at the evolution of randomized controlled trials: new and old ethical issues

Yazici H., ÖZGÜLER Y., ESATOĞLU S. N., Ozdede A., KARAKOÇ A.

CURRENT OPINION IN IMMUNOLOGY , cilt.100, 2026 (SCI-Expanded, Scopus)

3. ANCA-associated vasculitis presenting with tongue necrosis and severe gastrointestinal involvement

Karakoc A., Kopac S., Atas I., ERZİN Y. Z., EŞKAZAN T., Hatipoglu E., et al.

Clinical and Experimental Rheumatology , cilt.44, sa.4, ss.874-875, 2026 (SCI-Expanded, Scopus)

4. Turkish Society for Rheumatology recommendations for the diagnosis, follow-up and management of giant cell arteritis

ALİBAZ F., Kara M., ESATOĞLU S. N., KENAR ARTIN G., Uzun G. S., Ünlü B., et al.

Clinical and Experimental Rheumatology , cilt.44, sa.4, ss.647-662, 2026 (SCI-Expanded, Scopus)

5. Internal carotid artery involvement and stroke risk in Takayasu arteritis: a case–control study

Bukun H. O., UYGUNOĞLU U., Senturk E. F., Duru G., KIZILKILIÇ O., ESATOĞLU S. N., et al.

Rheumatology International , cilt.46, sa.3, 2026 (SCI-Expanded, Scopus)

6. Efficacy and tolerability of switching from coated to compressed colchicine preparations in patients with Behçet’s syndrome

Fidan S., ESATOĞLU S. N., ÖZGÜLER Y., UĞURLU S., SEYAHİ E., MELİKOĞLU M., et al.

Rheumatology , cilt.65, sa.2, 2026 (SCI-Expanded, Scopus)

7. New insights into the management of Behçet syndrome

ESATOĞLU S. N., ÖZGÜLER Y., HATEMİ G.

Expert Opinion on Investigational Drugs , cilt.35, sa.5, ss.329-339, 2026 (SCI-Expanded, Scopus)

8. Evaluation of Optical Coherence Tomography Angiography Parameters in Pulmonary, Ocular and Extrapulmonary Sarcoidosis

HEPOKUR M., Usta Küçükbezirci G., ATAHAN E., ESATOĞLU S. N., UÇAR D.

Ocular Immunology and Inflammation , cilt.34, sa.3, ss.572-578, 2026 (SCI-Expanded, Scopus)

9. Elucidating the Role of Neutrophils in the Inflammatory Response to Behcet Syndrome

ÖZGÜLER Y., ESATOĞLU S. N., HATEMİ G.

Journal of Inflammation Research , cilt.19, 2026 (SCI-Expanded, Scopus)

10. Safety outcome trials in four mainline medical journals 30 years apart: a narrative review and the need for the transparency of informed consents

ESATOĞLU S. N., Ozdede A., ÖZGÜLER Y., Tascilar K., Yazici H.

TRIALS , cilt.26, sa.1, 2025 (SCI-Expanded, Scopus)

11. Behcet's patient-derived HLA class I immunopeptidome is ERAP1-dependent and displays disease-specific candidate peptides

Haghighi Sabet A. B., Manches O., Aydin A. K., ÖZGÜLER Y., Yaylaz B. S., Workalemahu G., et al.

JOURNAL OF IMMUNOLOGY , cilt.214, 2025 (SCI-Expanded, Scopus)

12. Severe Visual Impairment in Behcet Syndrome in Time: A Comparison of Four Time Periods

ERDOĞAN M., Tascilar K., Ersoya Y., Ozcan A., Gurcan M., Ammar T., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.77, ss.4937-4939, 2025 (SCI-Expanded, Scopus)

13. Diagnostic value of vein wall thickness measurement for patients with suspected Behcet syndrome

Bayraktar R. A., KAYADİBİ Y., Kahveci A., ESATOĞLU S. N., ADALETLİ İ., ÖZGÜLER Y., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.77, ss.4939-4941, 2025 (SCI-Expanded, Scopus)

14. Efficacy and Safety of JAK Inhibitors in Behcet's Syndrome: A Systematic Literature Review

Sulu B., ESATOĞLU S. N., HATEMİ A. İ., ÇELİK A. F., HATEMİ G.

ARTHRITIS & RHEUMATOLOGY , cilt.77, ss.421-422, 2025 (SCI-Expanded, Scopus)

15. The Efficacy Of Targeted Therapies In Giant Cell Arteritis: A Systematic Review and Meta-Analysis

Kaymaz-Tahra S., Guneysu C. A., ESATOĞLU S. N., Uzun G. S., Ince B., Kara M., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.77, ss.1485-1486, 2025 (SCI-Expanded, Scopus)

16. Variability in phenotype clusters of Behçet's syndrome: A systematic review

Macit B., ESATOĞLU S. N., Akyuz-Yesilyurt K., HATEMİ G.

Seminars in Arthritis and Rheumatism , cilt.73, 2025 (SCI-Expanded, Scopus)

17. Factors associated with thrombosis in Behçet Syndrome: A systematic review and meta-analysis

Guzelant-Ozkose G., Yurttas B., ESATOĞLU S. N., AR M. C., Hamuryudan V., HATEMİ G.

Seminars in Arthritis and Rheumatism , cilt.73, 2025 (SCI-Expanded, Scopus)

18. De novo manifestations during adalimumab treatment in Behçet's syndrome

ESATOĞLU S. N., SÖNMEZ Ö., UÇAR D., Kaymaz E., ÖZGÜLER Y., UĞURLU S., et al.

RHEUMATOLOGY , cilt.64, sa.4, ss.2034-2040, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

19. Venous ulcers in Behçet syndrome

Karakoc A., ÖZGÜLER Y., Ozdede A., Ferhatoglu Z. A., Yildiz K. A., Kutlubay Z., et al.

Seminars in Arthritis and Rheumatism , cilt.71, 2025 (SCI-Expanded, Scopus)

20. Behçet syndrome with eye involvement

Uçar D., Esatoğlu S. N.

Saudi Journal of Ophthalmology , cilt.39, sa.1, ss.47-53, 2025 (ESCI, Scopus)

21. Development of Posterior Uveitis in Behçet Syndrome Patients with Vitreous Cells at Baseline

Uçar D., Bircan B. E., Rustamli N., Batu Oto B., Hamuryudan V., Hatemi G., et al.

Ocular Immunology and Inflammation , cilt.33, sa.2, ss.243-249, 2025 (SCI-Expanded, Scopus)

22. HLA-B gene methylation and expression in Behçet's syndrome: a potential role of epigenetics in the pathogenesis

Onen M. O., Everest E., Demirci T., Sen P. K., Kisakesen E. K., Ozguler Y., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , sa.10, ss.2014-2020, 2024 (SCI-Expanded, Scopus)

23. Tocilizumab may not be a good option for vascular involvement due to Behçet's syndrome.

Ozdede A., ESATOĞLU S. N., Durmaz E. Ş., Karakoc A., Ogun H., HATEMİ G., et al.

Clinical and experimental rheumatology , cilt.42, sa.10, ss.2057-2064, 2024 (SCI-Expanded, Scopus)

24. Validation of the Behçet's Syndrome Overall Damage Index (BODI) for retrospective studies and a proposal for modification

Ozogul Y. Y., ÖZGÜLER Y., ESATOĞLU S. N., UÇAR D., UYGUNOĞLU U., KUTLUBAY Z., et al.

RHEUMATOLOGY , 2024 (SCI-Expanded, Scopus)

25. Treatment of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review and meta-analysis.

ERDOĞAN M., ESATOĞLU S. N., Kilickiran Avci B., HATEMİ G.

Internal and emergency medicine , cilt.19, sa.3, ss.731-743, 2024 (SCI-Expanded, Scopus)

26. HLA-B gene methylation and expression in Behçet's syndrome: a potential role of epigenetics in the pathogenesis.

Özkılınç Önen M., Everest E., Demirci T., Köprülü Şen P., Kızıltepe Kısakesen E., Özgüler Y., et al.

Clinical and experimental rheumatology , 2024 (SCI-Expanded, Scopus)

27. Disease and Treatment-Specific Complications of Behçet Syndrome.

Esatoglu S. N., Ozguler Y., Hatemi G.

Current rheumatology reports , cilt.26, sa.1, ss.1-11, 2024 (SCI-Expanded, Scopus)

28. A Proposal of a New Tool for the Assessment of Damage in Behçet Syndrome Uveitis: Cerrahpasa Ocular Damage Grading System

Ozyazgan Y., UÇAR D., BATU OTO B., ESATOĞLU S. N., ÖZGÜLER Y., HATEMİ G., et al.

Ocular Immunology and Inflammation , cilt.32, sa.10, ss.2332-2338, 2024 (SCI-Expanded, Scopus)

29. Epidemiology of systemic vasculitis.

Ozguler Y., Esatoglu S. N., Hatemi G.

Current opinion in rheumatology , cilt.36, sa.1, ss.21-26, 2024 (SCI-Expanded, Scopus)

30. Mycophenolate mofetil may be an alternative for maintenance therapy of Behçet syndrome uveitis: a single-center retrospective analysis

UÇAR D., ESATOĞLU S. N., Cerme E., BATU OTO B., Hamuryudan V., SEYAHİ E., et al.

Rheumatology International , cilt.43, sa.11, ss.2099-2106, 2023 (SCI-Expanded, Scopus)

31. Abdominal Surgical Interventions Among Patients with Gastrointestinal Involvement of Behcet Syndrome

ESATOĞLU S. N., GÜNER S., Guler S., HATEMİ G., KEPİL N., ERZİN Y. Z., et al.

ARTHRITIS & RHEUMATOLOGY , ss.3068-3070, 2023 (SCI-Expanded, Scopus)

32. De Novo Manifestations During Adalimumab Treatment in Behcet Syndrome

ESATOĞLU S. N., SÖNMEZ Ö., UÇAR D., Kaymaz E., ÖZGÜLER Y., UĞURLU S., et al.

ARTHRITIS & RHEUMATOLOGY , ss.3070-3072, 2023 (SCI-Expanded, Scopus)

33. Treatment of Pulmonary Arterial Hypertension in Patients with Connective Tissue Diseases: A Meta-analysis

Erdogan M., ESATOĞLU S. N., KILIÇKIRAN AVCI B., HATEMİ G.

ARTHRITIS & RHEUMATOLOGY , ss.3001-3003, 2023 (SCI-Expanded, Scopus)

34. An Increase in Safety Outcome Trials and the Issue of Informed Consent

Ozdede A., ESATOĞLU S. N., Yazici H.

ARTHRITIS & RHEUMATOLOGY , ss.2007-2008, 2023 (SCI-Expanded, Scopus)

35. Central Nervous System Involvement and Mimickers in ANCA Associated Vasculitis

Ozogul Y. Y., ESATOĞLU S. N., Ozogul M., KIZILKILIÇ O., ÖZGÜLER Y., Uygunoglu U., et al.

ARTHRITIS & RHEUMATOLOGY , ss.3063-3065, 2023 (SCI-Expanded, Scopus)

36. Development of Posterior Uveitis in Behcet's Syndrome Patients with Vitreous Cells Without Any Other Posterior Involvement

UÇAR D., Bircan B. E., RUSTAMLI N., BATU OTO B., HAMURYUDAN V., ESATOĞLU S. N., et al.

ARTHRITIS & RHEUMATOLOGY , ss.3072-3073, 2023 (SCI-Expanded, Scopus)

37. Axial Spondyloarthritis in Patients with Gastrointestinal Involvement of Behcet Syndrome

ÖZTÜRK M., ESATOĞLU S. N., HATEMİ A. İ., ÇELİK A. F., KARGIN O. A., ÖZ A., et al.

ARTHRITIS & RHEUMATOLOGY , ss.3067-3068, 2023 (SCI-Expanded, Scopus)

38. Infliximab for vascular involvement in Behçet's syndrome.

Hatemi G., Tukek N. B., Esatoglu S. N., Ozguler Y., Taflan S. S., Uygunoglu U., et al.

Clinical immunology (Orlando, Fla.) , cilt.253, ss.109682, 2023 (SCI-Expanded, Scopus)

39. Juvenile and adult-onset scleroderma: Different clinical phenotypes.

Adrovic A., Karatemiz G., Esatoglu S. N., Yildiz M., Sahin S., Barut K., et al.

Seminars in arthritis and rheumatism , cilt.60, ss.152197, 2023 (SCI-Expanded, Scopus)

40. Current pharmacological solutions for Behçet’s syndrome

Ozguler Y., Esatoglu S. N., Hatemi G.

Expert Opinion on Pharmacotherapy , cilt.24, sa.2, ss.221-231, 2023 (SCI-Expanded, Scopus)

41. Frequency of AA amyloidosis has decreased in Behcet's syndrome: a retrospective study with long-term follow-up and a systematic review Amyloidosis in Behcet's syndrome

Karatemiz G., ESATOĞLU S. N., Gurcan M., ÖZGÜLER Y., YURDAKUL S., HAMURYUDAN V., et al.

RHEUMATOLOGY , cilt.62, sa.1, ss.9-18, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

42. A misinformative title and an abstract conclusion in the recent GWAS study in Behçet's Disease: Comment on the article by Su et al.

Sahin M. A., Esatoglu S. N.

Arthritis & rheumatology (Hoboken, N.J.) , cilt.74, ss.1723-1724, 2022 (SCI-Expanded, Scopus)

43. Outcome of Vascular Involvement of Behcet Syndrome Treated with Infliximab: A Retrospective Cohort Study

HATEMİ G., TÜKEK N. B., ESATOĞLU S. N., ÖZGÜLER Y., Taflan S. S., MELİKOĞLU M., et al.

ARTHRITIS & RHEUMATOLOGY , ss.3098-3099, 2022 (SCI-Expanded, Scopus)

44. Development of Posterior Uveitis in Behcet's Syndrome Patients with Vitreous Cells Without Any Other Posterior Involvement

UÇAR D., Bircan B. E., RUSTAMLI N., BATU OTO B., HAMURYUDAN V., ESATOĞLU S. N., et al.

ARTHRITIS & RHEUMATOLOGY , ss.3090-3091, 2022 (SCI-Expanded, Scopus)

45. Venous Halo Sign Detected with Superb Microvascular Imaging in Behcet Syndrome

KAYADİBİ Y., Ozguler Y., MELİKOĞLU M., ESATOĞLU S. N., ÜSTÜNDAĞ A., KİMYON U., et al.

ARTHRITIS & RHEUMATOLOGY , ss.2458-2459, 2022 (SCI-Expanded, Scopus)

46. Screening for latent tuberculosis before starting TNF-alpha inhibitors in a population with high BCG vaccination rates

Hacioglu A., Borekci Ş., Melikoglu M., Ozguler Y., Esatoglu S. N., Ugurlu S., et al.

Rheumatology International , cilt.42, sa.8, ss.1443-1451, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

47. Highlights of the 19th International Conference on Behçet’s Syndrome

Esatoglu S. N., ÖZGÜLER Y., Hamuryudan V.

Clinical and Experimental Rheumatology , cilt.40, sa.8, ss.1453-1460, 2022 (SCI-Expanded, Scopus)

48. Emergence of new manifestations during infliximab treatment in Behcet's syndrome

Tukek N. B., Esatoglu S. N., HATEMİ G., Caliskan E. B., Ozyazgan Y., Ucar D., et al.

RHEUMATOLOGY , cilt.61, sa.9, ss.3746-3753, 2022 (SCI-Expanded, Scopus)

49. Challenges in optimising patient participation in research: do patients participating in meetings represent the actual patient population with Behcet's syndrome?

Taflan S. S., ESATOĞLU S. N., ÖZGÜLER Y., YURTTAŞ B., MELİKOĞLU M., HATEMİ G.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.448-450, 2022 (SCI-Expanded, Scopus)

50. Takayasu arteritis.

Esatoglu S. N., Hatemi G.

Current opinion in rheumatology , cilt.34, sa.1, ss.18-24, 2022 (SCI-Expanded, Scopus)

51. Comparison of demographic and clinical characteristics of hospitalized COVID-19 patients with severe/critical illness in the first wave versus the second wave

Altunok E. S., Satici C., Dinc V., Kamat S., Alkan M., Demirkol M. A., et al.

JOURNAL OF MEDICAL VIROLOGY , cilt.94, sa.1, ss.291-297, 2022 (SCI-Expanded, Scopus)

52. Mediastinal lymphadenopathy may predict 30-day mortality in patients with COVID-19

Satici C., Cengel F., Gurkan O., Demirkol M. A., Altunok E. S., Esatoglu S. N.

CLINICAL IMAGING , cilt.75, ss.119-124, 2021 (SCI-Expanded, Scopus)

53. COVID-19 Among Patients With Inflammatory Rheumatic Diseases

Esatoglu S. N., Tascilar K., Babaoglu H., Bes C., YURTTAŞ B., AKAR S., et al.

FRONTIERS IN IMMUNOLOGY , cilt.12, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

54. Aortic involvement in relapsing polychondritis: case-based review.

Erdogan M., Esatoglu S. N., Hatemi G., Hamuryudan V.

Rheumatology international , cilt.41, sa.4, ss.827-837, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

55. The prognostic value of serum levels of a proliferation-inducing ligand (APRIL) in treatment-naive patients with chronic lymphocytic leukemia

Esatoğlu S. N., Keskin D., Eşkazan A. E., Elverdi T., Salihoğlu A., Ar M. C., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.1, ss.348-354, 2021 (SCI-Expanded, Scopus, TRDizin)

56. Immunogenicity of Infliximab Among Patients With Behçet Syndrome: A Controlled Study.

Esatoglu S. N., Akkoc-Mustafayev F. N., Ozguler Y., Ozbakır F., NOHUT O. K., Cevirgen D., et al.

Frontiers in immunology , cilt.11, ss.618973, 2020 (SCI-Expanded, Scopus)

57. Falsely low values of oxygen saturation measured by pulse oximetry in patients with coronavirus disease 2019

SATICI C., Demirkol M. A., Alkan M., ESATOĞLU S. N.

LUNG INDIA , cilt.37, sa.6, ss.553-554, 2020 (ESCI, Scopus)

58. Long term follow-up of Behçet's syndrome patients treated with cyclophosphamide.

Gurcan M., Esatoglu S. N., Hamuryudan V., Saygin D., Ugurlu S., Seyahi E., et al.

Rheumatology (Oxford, England) , cilt.59, sa.9, ss.2264-2271, 2020 (SCI-Expanded, Scopus)

59. Performance of pneumonia severity index and CURB-65 in predicting 30-day mortality in patients with COVID-19

Satici C., Demirkol M. A., Altunok E. S., Gursoy B., Alkan M., Kamat S., et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES , cilt.98, ss.84-89, 2020 (SCI-Expanded, Scopus)

60. Disease course and healthcare costs of a cohort of rheumatoid arthritis patients from Turkey

Ayan G., Esatoglu S. N., Hatemi G., HAMURYUDAN V.

RHEUMATOLOGY INTERNATIONAL , cilt.40, sa.7, ss.1037-1044, 2020 (SCI-Expanded, Scopus)

61. How to treat myelodysplastic syndrome with clinical features resembling Behcet syndrome: a case-based systematic review

Yilmaz U., Ar M. C., Esatoglu S. N., Bavunoglu I., Erzin Y. Z., Hatemi A. İ., et al.

ANNALS OF HEMATOLOGY , sa.6, ss.1193-1203, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

62. Frequency of lost to follow-up of rheumatoid arthritis and ankylosing spondylitis patients in a tertiary center

Esatoğlu S. N., Çelik F., Yeşilsancak M., Doymaz F., Uğurlu S.

Ulusal Romatoloji Dergisi , cilt.12, ss.7-11, 2020 (TRDizin)

63. Takayasu's arteritis: associated inflammatory diseases

Esatoglu S. N., Ok A. M., Ucar D., Celik A. F., Ugurlu S., Hamuryudan V., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.38, sa.2, 2020 (SCI-Expanded, Scopus)

64. Current surgical approaches in Takayasu's arteritis: a single-centre experience.

Arslan C., Tel Ç., Arapi B., Esatoglu S. N., Besirli K., Bozkurt A., et al.

Clinical and experimental rheumatology , cilt.38, sa.2, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

65. Tapering tumour necrosis factor inhibitors in rheumatoid arthritis: a retrospective study.

Hacioglu A., Hatemi G., Esatoglu S. N., Hamuryudan V.

Clinical and experimental rheumatology , sa.6, ss.8, 2019 (SCI-Expanded, Scopus)

66. Increased frequency of obstructive sleep apnea syndrome in Behçet's syndrome patients with superior vena cava syndrome.

Gokturk A., Esatoglu S. N., Atahan E., HAMURYUDAN V., Yazici H., Seyahi E.

Clinical and experimental rheumatology , sa.6, ss.132-136, 2019 (SCI-Expanded, Scopus)

67. Outcome of invasive procedures for venous thrombosis in Behçet's syndrome: case series and systematic literature review.

Dincses E., Esatoglu S. N., Fresko İ., MELİKOĞLU M., Seyahi E.

Clinical and experimental rheumatology , sa.6, ss.125-131, 2019 (SCI-Expanded, Scopus)

68. Is sirolimus a treatment option for patients with systemic lupus erythematosus?

Esatoglu S. N., SEYAHİ E.

Clinical and experimental rheumatology , sa.6, ss.13, 2019 (SCI-Expanded, Scopus)

69. Bone marrow oedema on sacroiliac/spine MRI: is it really a sign of objective inflammation warranting treatment?

Esatoglu S. N., Hatemi G.

Clinical and experimental rheumatology , sa.6, ss.10, 2019 (SCI-Expanded, Scopus)

70. Update on the treatment of Behcet's syndrome

ESATOĞLU S. N., HATEMİ G.

INTERNAL AND EMERGENCY MEDICINE , cilt.14, sa.5, ss.661-675, 2019 (SCI-Expanded, Scopus)

71. Secukinumab induced Behcet's syndrome: a report of two cases

DİNÇSES NAS E., YURTTAŞ B., ESATOĞLU S. N., MELİKOĞLU M., HAMURYUDAN V., SEYAHİ E.

OXFORD MEDICAL CASE REPORTS , sa.5, ss.239-241, 2019 (ESCI, Scopus)

72. Management of skin, mucosa and joint involvement of Behçet's syndrome: A systematic review for update of the EULAR recommendations for the management of Behçet's syndrome.

Leccese P., Ozguler Y., Christensen R., Esatoglu S. N., Bang D., Bodaghi B., et al.

Seminars in arthritis and rheumatism , cilt.48, sa.4, ss.752-762, 2019 (SCI-Expanded, Scopus)

73. Biosimilar infliximab for Behcet's syndrome: a case series

Dincses E., Esatoglu S. N., Ozguler Y., Uygunoglu U., Hamuryudan V., Seyahi E., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.37, sa.6, ss.111-115, 2019 (SCI-Expanded, Scopus)

74. Management of major organ involvement of Behçet's syndrome: a systematic review for update of the EULAR recommendations.

Ozguler Y., Leccese P., Christensen R., Esatoglu S. N., Bang D., Bodaghi B., et al.

Rheumatology (Oxford, England) , cilt.57, sa.12, ss.2200-2212, 2018 (SCI-Expanded, Scopus)

75. Faecal but not serum calprotectin levels look promising in predicting active disease in Behçet's syndrome patients with gastrointestinal involvement

Esatoglu S. N., Hatemi I., Ozguler Y., Hatemi G., Uzun H., Celik A. F., et al.

Clinical and experimental rheumatology , cilt.36, sa.6, ss.90-96, 2018 (SCI-Expanded, Scopus)

76. Highlights of the 18th International Conference on Behçet's syndrome

ESATOĞLU S. N., Kutlubay Z., HATEMİ G.

Clinical and experimental rheumatology , cilt.36, sa.6, ss.3-12, 2018 (SCI-Expanded, Scopus)

77. Rituximab for anti-neutrophil cytoplasmic antibodies-associated vasculitis: experience of a single center and systematic review of non-randomized studies

Ayan G., Esatoglu S. N., Hatemi G., Ugurlu S., Seyahi E., Melikoglu M., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.38, sa.4, ss.607-622, 2018 (SCI-Expanded, Scopus)

78. Türkiye romatoloji derneği aksiyel spondiloartrit ulusal tedavi önerileri

HATEMİ G., AKAR S., AKDOĞAN A., ATAGÜNDÜZ M. P., ersözlü e. d., ESATOĞLU S. N., et al.

Ulusal romatoloji dergisi , 2018 (Hakemli Dergi)

79. Considerations in designing and interpreting prevalence studies for Behcet syndrome

Hatemi G., Esatoglu S. N., Yurdakul S.

POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ , cilt.128, sa.3, ss.148-149, 2018 (SCI-Expanded, Scopus)

80. Biomarkers in vasculitis.

Hatemi G., Esatoglu S. N., Yazici Y.

Current opinion in rheumatology , cilt.30, sa.1, ss.30-35, 2018 (SCI-Expanded, Scopus)

81. Exacerbation of Behçet's syndrome and familial Mediterranean fever with menstruation.

Guzelant G., Ozguler Y., Esatoglu S. N., Karatemiz G., Ozdogan H., Yurdakul S., et al.

Clinical and experimental rheumatology , sa.6, ss.95-99, 2017 (SCI-Expanded, Scopus)

82. Infliximab for uveitis of Behçet's syndrome: a trend for earlier initiation.

Guzelant G., Ucar D., Esatoglu S. N., Hatemi G., Ozyazgan Y., Yurdakul S., et al.

Clinical and experimental rheumatology , sa.6, ss.86-89, 2017 (SCI-Expanded, Scopus)

83. Developing a Core Set of Outcome Measures for Behçet Disease: Report from OMERACT 2016.

Hatemi G., Meara A., Ozguler Y., Direskeneli H., Mahr A., Easley E., et al.

The Journal of rheumatology , cilt.44, sa.11, ss.1750-1753, 2017 (SCI-Expanded, Scopus)

84. What is the long term acid inhibitor treatment in gastroesophageal reflux disease? What are the potential problems related to long term acid inhibitor treatment in gastroesophageal reflux disease? How should these cases be followed?

HATEMI I., Esatoğlu S. N.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.28, 2017 (SCI-Expanded, Scopus, TRDizin)

85. Behçet's syndrome: providing integrated care.

Esatoglu S. N., Kutlubay Z., Ucar D., Hatemi I., Uygunoglu U., Siva A., et al.

Journal of multidisciplinary healthcare , cilt.10, ss.309-319, 2017 (Scopus)

86. Long-term follow-up of secondary amyloidosis patients treated with tumor necrosis factor inhibitor therapy: A STROBE-compliant observational study.

Esatoglu S. N., Hatemi G., Ugurlu S., Gokturk A., Tascilar K., Ozdogan H.

Medicine , cilt.96, sa.34, 2017 (SCI-Expanded, Scopus)

87. Missing Information About Disease Controls: Comment on the Article by Mangnus et al

Esatoglu S. N., Seyahi E., Yazici H.

ARTHRITIS & RHEUMATOLOGY , cilt.69, sa.3, ss.678, 2017 (SCI-Expanded, Scopus)

88. Bronchial artery enlargement may be the cause of recurrent haemoptysis in Behcet's syndrome patients with pulmonary artery involvement during follow-up

Esatoglu S. N., Seyahi E., Ugurlu S., Gulsen F., Akman C., Cantasdemir M., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.6, 2016 (SCI-Expanded, Scopus)

89. Associated Inflammatory Diseases in Takayasu's Arteritis: The Many Faces of a Disease

Esatoglu S. N., Celik A. M., UÇAR D., Celik A. F., UĞURLU S., HATEMİ G., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded, Scopus)

90. Highlights of the 17th International Conference on Behçet's syndrome

ESATOĞLU S. N., HATEMİ G., Leccese P., Olivieri I.

Clinical and Experimental Rheumatology , cilt.34, ss.3-9, 2016 (SCI-Expanded, Scopus)

91. Characteristics, treatment, and long-term outcome of gastrointestinal involvement in behcet's syndrome a strobe-compliant observational study from a dedicated multidisciplinary center

Hatemi I., Esatoglu S. N., Hatemi G., Erzin Y. Z., Yazici H., Celik A. F.

Medicine (United States) , cilt.95, sa.16, 2016 (SCI-Expanded, Scopus)

92. A reappraisal of the association between Behcet's disease, myelodysplastic syndrome and the presence of trisomy 8: a systematic literature review

Esatoglu S. N., Hatemi G., Çelik A. F., Hatemi I., Soysal T., Çelik A. B.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.33, sa.6, 2015 (SCI-Expanded, Scopus)

93. Bone marrow transplantation for Behçet's disease: A case report and systematic review of the literature

Soysal T., Salihoglu A., Esatoglu S. N., Gulturk E., Eskazan A. E., Hatemi G., et al.

Rheumatology (United Kingdom) , cilt.53, sa.6, ss.1136-1141, 2014 (SCI-Expanded, Scopus)

94. Primary osteosarcoma of the heart: Experience of an unusual case

Özen D. S. K., Öztürk M. A., Selcukbiricik F., Esatoglu S. N., Turna Z. H., Beyaz P., et al.

Case Reports in Oncology , cilt.6, sa.1, ss.224-228, 2013 (SCI-Expanded, ESCI, Scopus)

95. Breast schwannoma in a patient with diffuse large B-cell lymphoma: a case report.

Salihoglu A., Esatoglu S. N., Eskazan A. E., Halac M., Aydin S.

Journal of medical case reports , cilt.6, ss.423, 2012 (Scopus)

96. Kolesterol Embolisi: Gözden Kaçabilen bir Tanı

ESATOĞLU S. N.

Türk Nefroloji Diyaliz ve Transplantasyon Dergisi , cilt.21, sa.1, ss.101-104, 2012 (SCI-Expanded, SSCI, Scopus, TRDizin)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 14

1. DISEASE COURSE AND COSTS OF A COHORT OF RHEUMATOID ARTHRITIS PATIENTS OVER A PERIOD OF 6 YEARS

Ayan G., Esatoglu S. N., Hatemi G., Hamuryudan V.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1577-1578, (Özet Bildiri)

2. INITIAL MANIFESTATIONS AND OUTCOME OF PATIENTS WITH INCOMPLETE BEHCET'S SYNDROME

ESATOĞLU S. N., BİLGİN S., SULU C., HAMURYUDAN V., KUTLUBAY Z., UĞURLU S., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.428, (Özet Bildiri)

3. EVIDENCE BASED RECOMMENDATIONS FOR THE MANAGEMENT OF ENTEROPATHIC ARTHRITIS: A RHEUMATOLOGY, GASTROENTEROLOGY COLLABORATIVE INITIATIVE

HATEMİ G., AKAR S., AKPINAR H., Atagunduz P., Bengi G., CAN G., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.881, (Özet Bildiri)

4. MYCOPHENOLATE MOFETIL IN THE TREATMENT OF MAJOR ORGAN INVOLVEMENT OF PATIENTS WITH BEHCET'S SYNDROME

ESATOĞLU S. N., Cemre E., HAMURYUDAN V., ÖZYAZGAN Y., UÇAR D., KUTLUBAY Z., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.820, (Özet Bildiri)

5. AORTIC INVOLVEMENT IN RELAPSING POLYCHONDITIS: A SYSTEMATIC REVIEW

Erdogan M., Esatoglu S. N., Hatemi G., Hamuryudan V.

19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, (Özet Bildiri)

6. The Evaluation of Cytogenetics Results Obtained from Behçet Disease with Gastrointestınal Involment

YILMAZ Ş., ESATOĞLU S. N., Kuru D., SALİHOĞLU A., ÇIRAKOĞLU A., HATEMİ G., et al.

13th National Congress of Medical Genetics with International Participation, Antalya, Türkiye, 7 - 11 Kasım 2018, ss.30, (Özet Bildiri)

7. Could neurological involvement in Behcet's Disease occur atypically?

Siva A., Esatoglu S. N., Uygunoglu U., Ozguler Y., Hatemi G., Tutuncu M., et al.

70th Annual Meeting of the American-Academy-of-Neurology (AAN), Los-Angeles, Şili, 21 - 27 Nisan 2018, cilt.90, (Özet Bildiri)

8. ASSOCIATED INFLAMMATORY SYNDROMES IN TAKAYASU'S ARTERITIS: MANY FACES OF A DISEASE

Esatoglu S. N., Celik A. M., Ucar D., Celik A. F., Ugurlu S., Hatemi G., et al.

Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.618, (Özet Bildiri)

9. SYSTEMATIC REVIEW ON THE TREATMENT OF SKIN, MUCOSA AND JOINT INVOLVEMENT OF BEHCET'S SYNDROME INFORMING THE EULAR RECOMMENDATIONS FOR THE MANAGEMENT OF BEHCET'S SYNDROME

Leccese P., Ozguler Y., Christensen R., Esatoglu S. N., Olivieri I., Yazici H., et al.

18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.89, (Özet Bildiri)

10. RELATIONSHIP BETWEEN MENSTRUATION AND SYMPTOMS OF BEHCET'S SYNDROME

Guzelant G., Ozguler Y., Esatoglu S. N., Karatemiz G., Ozdogan H., Yurdakul S., et al.

18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.92, (Özet Bildiri)

11. ASSOCIATED INFLAMMATORY DISEASES IN TAKAYASU'S ARTERITIS: THE MANY FACES OF A DISEASE

Esatoglu S. N., Celik A. M., Ucar D., Ugurlu S., Hatemi G., Hamuryudan V., et al.

18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.47, (Özet Bildiri)

12. EARLIER USE OF INFLIXIMAB FOR THE UVEITIS OF BEHCET'S SYNDROME APPEARS TO BE ASSOCIATED WITH BETTER OUTCOME

Guzelant G., Guzelant G., Ucar D., Hatemi G., Ozyazgan Y., Esatoglu S. N., et al.

18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.94, (Özet Bildiri)

13. A SYSTEMATIC LITERATURE REVIEW ON THE TREATMENT OF MAJOR ORGAN INVOLVEMENT OF BEHCET'S SYNDROME INFORMING THE EULAR RECOMMENDATIONS FOR THE MANAGEMENT OF BEHCET'S SYNDROME

Ozguler Y., Leccese P., Christensen R., Esatoglu S. N., Olivieri I., Yazici H., et al.

18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.89, (Özet Bildiri)

14. Elementer pseudo-siyanoz üçlemesi

İKİZCELİ İ., BALTA M., BAVUNOĞLU I., AKDENİZ Y. S., ESATOĞLU S. N.

VII. Ulusal Acil Tıp Kongresi, Antalya, Türkiye, 26 - 29 Mayıs 2011, sa.306, ss.292, (Tam Metin Bildiri)

Metrikler

Yayın

149

Yayın (WoS)

106

Yayın (Scopus)

Atıf (WoS)

1049

H-İndeks (WoS)

Atıf (Scopus)

1229

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler